Overview: Succinylacetone TestIntroduction: The Succinylacetone Test measures succinylacetone to diagnose tyrosinemia, causing liver or kidney issues. Aligned with 2023 AAP guidelines, it uses biochemical methods for high specificity, supporting metabolic screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected tyrosinemia.
Other Names: Succinylacetone Assay, Tyrosinemia Metabolic Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Succinylacetone testing began in the 1970s with tyrosinemia research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures succinylacetone to diagnose tyrosinemia, guides treatment, and evaluates patients with liver or kidney issues.
Test Parameters: 1. Succinylacetone Level 2. Metabolite Presence
Pretest Condition: No fasting required. Collect whole blood or urine. Report history of liver, kidney issues, or metabolic symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL), Urine (sterile container, 5-20 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document liver, kidney issues, or history of metabolic disorders. Include current medications, especially nitisinone.
Consent: Written consent required, detailing the tests purpose, tyrosinemia implications, and risks of sample collection.
Procedural Considerations: Uses liquid chromatography-mass spectrometry (LC-MS) to measure succinylacetone and metabolites. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for tyrosinemia diagnosis.
Factors Affecting Result Accuracy: Improper sample storage or contamination can affect results. Medications like nitisinone may alter levels.
Clinical Significance: Elevated succinylacetone confirms tyrosinemia, guiding nitisinone therapy or dietary management. Normal levels may require genetic testing.
Specialist Consultation: Consult a metabolic specialist or pediatrician for result interpretation and treatment planning.
Additional Supporting Tests: Tyrosine levels, genetic testing, or liver function tests to confirm tyrosinemia diagnosis.
Test Limitations: Non-specific for certain metabolic disorders; clinical correlation is needed. Sample quality affects sensitivity.
References: AAP Metabolic Guidelines, 2023; Journal of Inherited Metabolic Disease, Chinsky JM, 2022.
